Polymyxin E Sulfate-Loaded Liposome for Intravenous Use: Preparation, Lyophilization, and Toxicity Assessment In Vivo

References

1. 1.↵
   1. Evans M. E.,
   2. Feola D. J.,
   3. Rapp R. P.,

   Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann. Pharmacother 1999, 33 ( 9), 960– 967.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Brown J. M.,
   2. Dorman D. C.,
   3. Roy L. P.,

   Acute renal failure due to overdosage of colistin. Medical Journal of Australia 1970, 2, 923– 924.

   OpenUrlPubMedWeb of Science
3. 3.↵
   1. Koch-Weser J.,
   2. Sidel V. W.,
   3. Federman E. B.,
   4. Kanarek P.,
   5. Finer D. C.,
   6. Eaton A. E.,

   Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann. Int. Med. 1970, 72, 857– 868.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Obritsch M. D.,
   2. Fish D. N.,
   3. MacLaren R,
   4. Jung R.,

   Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy 2005, 25 ( 10), 1353– 1364.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Mehta R. T.,

   Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium–M. intracellulare complex infection. Antimicrob. Agents Chemother 1996, 40 ( 8), 1893– 1902.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Yeqing G.,
   2. Chunhe S,
   3. Di C.,

   Retinal toxicity of liposome-encapsulated 5-fluorouracil administered intravitreally. Chinese Journal of Ocular Trauma and Occupational Eye Disease 2005, 27 ( 12), 884– 886.

   OpenUrl
7. 7.↵
   1. Takemoto K.,
   2. Yamamoto Y.,
   3. Ueda Y.,
   4. Sumita Y.,
   5. Yoshida K.,
   6. Niki Y.,

   Comparative studies on the efficacy of AmBisome and Fungizone in a mouse model of disseminated aspergillosis. J. Antimicrob. Chemother 2004, 53 ( 2), 311– 317.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Gregoriadis G.,

   1. Defrise Q.,
   2. Chatelain F. P.,
   3. Delmelle M.,
   4. et al.,

   Model Studies for Drug Entrapment and Liposomes Stability. In Liposomes Technology: Incorporation of Drugs, Proteins, and Genetic Material; Gregoriadis G., Ed.; CRC Press: Boca Raton, FL, 1984; pp 1– 17.
9. 9.↵
   1. Baoguo L.,
   2. Zezhao H.,
   3. Zhanjie L.,

   Freeze-drying of liposomes and its effect on retention rate of encapsulated pharmaceuticals. Journal of Huanan University of Arts and Science (Natural Science Edition) 2003, 15 ( 3), 44– 50

   OpenUrl
10. 10.↵
    1. Lu B.,

    New Techniques and New Dosage Forms of Drugs; People's Health Press: Beijing, 1998; p 127.
11. 11.↵
    1. Monnard PA,
    2. Oberholzer T.,
    3. Luisi P.,

    Entrapment of nucleic acids in liposomes []. Biochim Biophys Acta. 1997, 1329( 1):39– 50.

    OpenUrlPubMed
12. 12.↵
    1. Jiansong W,
    2. Jiabi Z.,

    Preparation of azithromycin liposome and its entrapment efficiency determination. China Pharm. Univ 2004, 35 ( 6), 499– 502.

    OpenUrl
13. 13.↵
    1. Liwen K.,
    2. Dongkai W.,
    3. Jing W.,
    4. et al.,

    Effects of different preparation methods for polymyxin E sulfate liposomes on its encapsulation efficiency. Journal of Shenyang Pharmaceutical University 2007, 12 ( 24), 727– 730.

    OpenUrl
14. 14.
    1. Han J.,
    2. Su D.,

    Studies on the physical properties of an anticancer drug FT-207 fat emulsion. Journal of Shengyang College of Pharmacy 1991, 8 ( 1), 14.

    OpenUrl
15. 15.↵
    1. Nounou M. M.,
    2. El-Khordagui L. K.,
    3. Khalafallah N. A.,
    4. et al.,

    In vitro release of hydrophilic and hydrophobic drugs from liposomal dispersions and gels. Acta Pharm. 2006, 56, 311– 324.

    OpenUrlPubMed
16. 16.↵
    1. Xu Z.-Y.,
    2. Chen Z,
    3. Hou L.-B,

    Quality evaluation of ofloxacin liposomes prepared by a pH-gradient method. WCJ.PS 2000, 15, 443– 444.

    OpenUrl
17. 17.↵
    1. Deng Y.,
    2. Yu B.,
    3. Li H.,
    4. et al.,

    Preparation of adriamycin liposomes by a pH-gradient method. Journal of Shenyang Pharmaceutical University 1997, 14, 239– 242.

    OpenUrl
18. 18.↵
    1. Zhang Q.,
    2. Deng Y.,

    The preparation of 5-FU liposome by a freeze-thawing method and the study on its stability. Journal of Shenyang Pharmaceutical University 2000, 17 ( 2), 87– 89.

    OpenUrl
19. 19.↵
    1. MaoQuan C.,
    2. Hongchen G.,
    3. GuoJie L.,

    Preparation and stability of tanshinone liposomes. Chinese Journal of Pharmaceuticals 2001, 32 ( 9), 400– 404.

    OpenUrl
20. 20.↵
    1. Cócera M.,
    2. López O.,
    3. Coderch L.,
    4. et al.,

    Alterations in stratum corneum lipid liposomes due to the action of Triton X-100: Influence of the level of ceramides on this process. J. Controlled Release 2000, 68, 387– 396.

    OpenUrlPubMed
21. 21.↵
    1. VanWinden E. C.,
    2. Zhang W.,
    3. Cormmelin D. J.,

    Effect of freezing rate on the stability of liposomes during freeze-drying and rehydration. Pharm. Res 1997, 14 ( 9), 1151– 1160.

    OpenUrlPubMed
22. 22.↵
    1. Crowe L. M.,
    2. Crowe J. H.,

    Stabilization of dry liposomes by carbohydrates. Dev. Biol. Stand 1991, 74 ( 4): 285– 294.

    OpenUrl